TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 156 filers reported holding TRAVERE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $325,023 | -39.7% | 36,356 | +3.7% | 0.00% | -33.3% |
| Q2 2023 | $538,568 | -19.4% | 35,063 | +18.1% | 0.00% | -25.0% |
| Q1 2023 | $667,908 | +9.1% | 29,698 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $612,120 | -14.0% | 29,107 | +0.7% | 0.00% | -20.0% |
| Q3 2022 | $712,000 | +3.0% | 28,913 | +1.4% | 0.01% | 0.0% |
| Q2 2022 | $691,000 | -8.5% | 28,505 | -2.7% | 0.01% | +25.0% |
| Q1 2022 | $755,000 | -22.5% | 29,311 | -6.6% | 0.00% | -20.0% |
| Q4 2021 | $974,000 | +25.8% | 31,375 | -1.7% | 0.01% | +25.0% |
| Q3 2021 | $774,000 | +62.3% | 31,907 | -2.3% | 0.00% | +100.0% |
| Q2 2021 | $477,000 | -40.7% | 32,665 | +1.3% | 0.00% | -33.3% |
| Q1 2021 | $805,000 | +3.9% | 32,248 | +13.4% | 0.00% | 0.0% |
| Q4 2020 | $775,000 | – | 28,439 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |